WebNov 13, 2024 · Learn more and invest at biolife4d.com. Follow us on social media @BIOLIFE4D. Although you are currently able to express your interest in investing, BIOLIFE4D Corporation is not yet accepting investments. No money or other consideration is being solicited by the company at this time, and if sent in response, will not be accepted. WebBioLife4D Corp. filed its S-1 (prospectus) on June 3, 2024. The company’s IPO is a unit offering consisting of stock and warrants. ... (Wall Street Consensus of Opening-day Premiums), is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The ...
Biolife4D Corp. Increases Size of Planned IPO - MarketWatch
WebMar 14, 2024 · BIOLIFE4D’s plans for an IPO are detailed in the S-1 registration statement it submitted to the SEC last week. In what is a lengthy document, the firm outlines how it … WebA high-level overview of BIOLIFE4D Corporation (SAVU) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. gpte international ltd
Bioprinting Human Hearts for Transplant - BIOLIFE4D
WebBioLife4D Corporation is a pioneering biotech company that plans to leverage current advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation – potentially lifesaving technology that ultimately gives patients the gift of time. We are committed to perfecting the technology to make viable organ ... WebDec 19, 2024 · Biolife4D Corp. on Monday said it was raising the size of its planned initial public offering to 3.6 million units from 2.4 million. The units are still expected to price between $5.20 and $7.20 ... WebSep 7, 2024 · Financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death among both men and women globally. Learn more and invest at www.biolife4d.com. Although you are currently able to express your interest in investing, BIOLIFE4D Corporation is not yet accepting … gpt edge extension